ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model

Hurt-Camejo Eva

首页> 外文期刊>Journal of Lipid Research >ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model

【24h】

ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model

机译：Angptl3，PCSK9和他汀类药物治疗在小鼠模型中的高脂血症和动脉粥样硬化方面的效果显着降低

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Lipid Research》 |2020年第3期|共3页
作者
Hurt-Camejo Eva;
展开▼
作者单位

AstraZeneca Translat Sci &

Expt Med Res &

Early Dev Cardiovasc Renal &

Metab BioPharmaceut R&

D;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类生物化学;
关键词
入库时间 2022-08-20 09:31:03

相似文献

外文文献
中文文献
专利

1. ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model [J] . Hurt-Camejo Eva Journal of Lipid Research . 2020,第3期

机译：Angptl3，PCSK9和他汀类药物治疗在小鼠模型中的高脂血症和动脉粥样硬化方面的效果显着降低
2. Use of PCSK9 Inhibitor Therapy in a Small Cohort of Heart Transplant Recipients with Statin Intolerance or Refractory Hyperlipidemia [J] . Jackson R., Jennings D., Gaine M., The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation . 2019,第4Suppla期

机译：使用PCSK9抑制剂治疗在小型心脏移植受者的小群体中，用他汀类药物或难治性高脂血症
3. Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemia [J] . MaL., BallantyneC.M., BelmontJ.W., Journal of Lipid Research . 2012,第11期

机译：在他汀类药物非诺贝酸治疗混合血脂异常的患者中，RXRA和ANGPTL3基因附近的SNP之间的相互作用抑制了载脂蛋白B的减少
4. Smoking-Related Low HDL-C Level and Regression of Coronary Atherosclerosis during Statin Therapy (from the JAPAN-ACS study) [C] . Ando J., Hirata Y., Nagai R., World Congress on Heart Disese-International Academy of Cardiology Annual Scientific Session 2010 . 2010

机译：吸烟相关的低HDL-C水平和冠状动脉粥样硬化期间的冠状动脉粥样硬化（来自日本ACS研究）
5. The regression of atherosclerosis: Molecular insights from novel mouse models. [D] . Feig, Jonathan E. 2009

机译：动脉粥样硬化的回归：新型小鼠模型的分子见解。
6. ANGPTL3 PCSK9 and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model [O] . Eva Hurt-Camejo 2020

机译：ANGPTL3PCSK9和他汀类药物疗法可在小鼠模型中显着降低高脂血症和动脉粥样硬化
7. ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model [O] . Eva Hurt-Camejo 2020

机译：Angptl3，PCSK9和他汀类药物治疗在小鼠模型中的高脂血症和动脉粥样硬化方面促进了显着的减少
8. Formulated Delivery of Enzyme/Prodrug and Cytokine Gene Therapy to Promote Immune Reduction of Treated and Remote Tumors in Mouse Models of Prostate Cancer [R] . Russell, P. J. , Khatri, A. , Husaini, Y. , 2007

机译：配方递送酶/前药和细胞因子基因治疗促进小鼠前列腺癌模型中治疗和远程肿瘤的免疫减少

ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model

著录项

相似文献

相关主题

期刊订阅